Area of research
Molecular Biology · Genetics
Research interest
Research focused on Pomalidomide and Daratumumab, with related work in Carfilzomib, Ulcerative colitis, Autophagy. Notable publications include 'Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma', 'Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome', and 'Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma'.
A 2:1 randomized, open-label, phase II study of selinexor vs. physician’s choice in older patients with relapsed or refractory acute myeloid leukemia
Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in <scp>MAMMOTH</scp>
Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma
Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome
Basic Fibroblast Growth Factor Influences Epidermal Homeostasis of Living Skin Equivalents through Affecting Fibroblast Phenotypes and Functions